4/16
02:00 pm
amlx
Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm
Low
Report
Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm
4/16
11:35 am
amlx
Is Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) the Best Biotech Penny Stock to Buy According to Hedge Funds? [Yahoo! Finance]
Low
Report
Is Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) the Best Biotech Penny Stock to Buy According to Hedge Funds? [Yahoo! Finance]
4/11
07:22 am
amlx
Eric Dane reveals ALS diagnosis: What to know about the rare disease [USA TODAY]
Medium
Report
Eric Dane reveals ALS diagnosis: What to know about the rare disease [USA TODAY]
4/9
07:42 am
amlx
Amylyx Pharmaceuticals Announces First Participant Dosed in Phase 1, Multiple Ascending Dose LUMINA Trial of AMX0114 in People Living with Amyotrophic Lateral Sclerosis [Yahoo! Finance]
High
Report
Amylyx Pharmaceuticals Announces First Participant Dosed in Phase 1, Multiple Ascending Dose LUMINA Trial of AMX0114 in People Living with Amyotrophic Lateral Sclerosis [Yahoo! Finance]
4/9
07:00 am
amlx
Amylyx Pharmaceuticals Announces First Participant Dosed in Phase 1, Multiple Ascending Dose LUMINA Trial of AMX0114 in People Living with Amyotrophic Lateral Sclerosis
Medium
Report
Amylyx Pharmaceuticals Announces First Participant Dosed in Phase 1, Multiple Ascending Dose LUMINA Trial of AMX0114 in People Living with Amyotrophic Lateral Sclerosis
4/7
08:55 am
amlx
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $7.00 price target on the stock.
Medium
Report
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $7.00 price target on the stock.
4/2
09:00 am
amlx
Amylyx Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
High
Report
Amylyx Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
3/27
08:04 pm
amlx
Is Amylyx Pharmaceuticals (AMLX) The Hot Biotech Stock Under $5? [Yahoo! Finance]
Medium
Report
Is Amylyx Pharmaceuticals (AMLX) The Hot Biotech Stock Under $5? [Yahoo! Finance]
3/5
07:07 pm
amlx
Amylyx Pharmaceuticals Inc (AMLX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals Inc (AMLX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
3/5
08:11 am
amlx
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Medium
Report
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
3/4
06:17 am
amlx
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
3/4
06:00 am
amlx
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
Medium
Report
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
2/25
09:27 am
amlx
Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
2/25
09:00 am
amlx
Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences
Low
Report
Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences
2/24
09:18 am
amlx
Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 [Yahoo! Finance]
2/24
09:00 am
amlx
Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
High
Report
Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
2/18
07:28 am
amlx
Nura Bio Expands Leadership Team with C-Suite Appointments [Yahoo! Finance]
Medium
Report
Nura Bio Expands Leadership Team with C-Suite Appointments [Yahoo! Finance]
2/10
09:54 am
amlx
Amylyx Pharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
2/10
09:00 am
amlx
Amylyx Pharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Medium
Report
Amylyx Pharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
2/4
10:00 am
amlx
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Reach Out
Medium
Report
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Reach Out
2/3
10:00 am
amlx
Bronstein, Gewirtz & Grossman, LLC Is Investigating Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Connect
Low
Report
Bronstein, Gewirtz & Grossman, LLC Is Investigating Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Connect
2/2
10:00 am
amlx
Amylyx Pharmaceuticals, Inc. (AMLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Medium
Report
Amylyx Pharmaceuticals, Inc. (AMLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
1/31
03:40 pm
amlx
Amylyx Pharmaceuticals (AMLX) Upgraded to Buy: What Does It Mean for the Stock? [Yahoo! Finance]
Neutral
Report
Amylyx Pharmaceuticals (AMLX) Upgraded to Buy: What Does It Mean for the Stock? [Yahoo! Finance]
1/31
10:00 am
amlx
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Amylyx Pharmaceuticals, Inc. (AMLX) and Encourages Stockholders to Learn More About the Investigation
Low
Report
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Amylyx Pharmaceuticals, Inc. (AMLX) and Encourages Stockholders to Learn More About the Investigation
1/30
11:00 am
amlx
Bronstein, Gewirtz & Grossman, LLC Encourages Amylyx Pharmaceuticals, Inc. (AMLX) Investors to Inquire about Securities Investigation
Neutral
Report
Bronstein, Gewirtz & Grossman, LLC Encourages Amylyx Pharmaceuticals, Inc. (AMLX) Investors to Inquire about Securities Investigation